The EBMT (UK) NAP Committee welcomes you. As part of the main EBMT group we exist to provide education and networking opportunities for all healthcare professionals involved in the care of stem cell transplant patients in the UK.

 
We meet once a year but have now developed this site to give opportunities to network outside of the meetings. Please take a moment to register so that you receive regular updates and information about our meetings. As more details become available on the forthcoming meeting you will be able to register through this site.
Please register for membership of the site as it will be great to start sharing ideas.
 

Managing children with CML (up to age 18)

Guideline written by International paediatric CML group, full article in Learning section, summary below

Chronic myeloid leukaemia in children and young people is a relatively rare form of leukaemia that shows increased incidence with age and some evidence suggests that the molecular basis differs from that in adults. Significant advances in targeted therapy with the development and use in children of tyrosine kinase inhibitors and the ability to monitor and understand the prognostic significance of minimal residual disease by standardized molecular techniques has shifted the management of this condition from bone marrow transplantation as the main therapeutic modality to individualized treatment for each patient based on achieving specific milestones. The physiological changes occurring during childhood, particularly those affecting growth and development and the long-term use of treatment, pose specific challenges in this age group, which we are only beginning to understand.

Top